CorMedix (CRMD) Income from Continuing Operations (2010 - 2025)

CorMedix has disclosed Income from Continuing Operations across 16 years of filings, most recently posting 14020141.0 for Q4 2025.

• Income from Continuing Operations for Q4 2025 came in at 14020141.0, down 56.9% year-over-year; the trailing twelve-month figure through Dec 2025 was 163055000.0 (up 14253.43% YoY), and the FY2025 annual result was 163055000.0, up 14253.43% from the prior year.
• Income from Continuing Operations came in at 14020141.0 for Q4 2025 at CorMedix, down from 108562980.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 108562980.0 in Q3 2025 to a low of 14466123.0 in Q1 2024.
• The 5-year median for Income from Continuing Operations is 7408433.0 (2021), against an average of 2923599.0.
• Across the five-year window, Income from Continuing Operations plunged 74.94% in 2023 and jumped 4009.63% in 2025, its largest moves.
• CorMedix's Income from Continuing Operations stood at 9667173.0 in 2021, then increased by 15.08% to 8208951.0 in 2022, then slumped by 74.94% to 14360822.0 in 2023, then surged by 326.52% to 32530424.0 in 2024, then slumped by 56.9% to 14020141.0 in 2025.
• The last three Income from Continuing Operations figures came in at 14020141.0 (Q4 2025), 108562980.0 (Q3 2025), and 19827981.0 (Q2 2025), per Business Quant data.